ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01085656
Recruitment Status : Terminated
First Posted : March 12, 2010
Last Update Posted : August 8, 2017
Sponsor:
Collaborator:
The Leukemia and Lymphoma Society
Information provided by (Responsible Party):
University of Florida

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : January 2016
  Actual Study Completion Date : January 2016